Hereditary angioedema: recommendations

It is essential for patients to actively participate in the monitoring and treatment of their disease to increase their personal satisfaction and autonomy. Having reliable, verifiable information is also of great help in managing the disease.

Hereditary angioedema is such a rare disease that it is little-known even among healthcare workers. This means that in this case the patients themselves particularly need to know how to act in the event of an emergency, especially when they are not in their usual environment or are far away from their medical team.

Angioedema hereditari
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 01.02.2022, 18:45
Share it

Hereditary angioedema

Hereditary angioedema is a rare genetic disease that affects approximately one in 50,000 people. It is usually an inherited disorder and is characterised by the accumulation of fluids outside the blood vessels, causing swelling of the face, hands, feet, extremities, genitals, gastrointestinal tract or the upper respiratory tract. Because it is a low-prevalence disease with symptoms similar to those of other diseases and is therefore difficult to diagnose, it is important for there to be reference centres so that suspected and diagnosed cases can be centralised.

Angioedema hereditari
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 25.01.2022, 16:57
Share it

Rare diseases

Minority diseases, also called rare diseases, are those that affect between 5% and 7% of the population. They are very varied, affecting different parts of the body with a wide range of symptoms that change both between diseases and within the same disease. It is estimated that some 30 million people in the EU, 3 million in Spain, and around 350,000 in Catalonia suffer from one.

Malalties minoritàries
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 28.02.2025, 12:16
Share it

Orbital tumours

A tumour is an abnormal growth of tissue. In the case of orbital tumours, this growth is located in the tissues around the eye, which may be muscles, bones, fat, the lacrimal gland, nerves and blood vessels. They are rare tumours of several different types that may appear at any age. Orbital tumours may be benign or malignant. Benign tumours may cause pain due to compressing or displacing the different structures in the eye socket. Malignant tumours, on the other hand, as well as spreading to neighbouring tissue, may produce metastasis in other unconnected organs or lymphatic nodules.

Tumors d’òrbita a Vall d'Hebron
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 05.01.2023, 13:01
Share it

Inherited bone marrow failure syndromes

These syndromes are a group of diseases characterised by insufficient blood cell production (anaemia, neutropenia and thrombocytopenia), constitutional malformations and the risk of cancer.

 

They are usually diagnosed in childhood but there some cases diagnosed in adults. Specifically, these syndromes are:  Fanconi anaemia, dyskeratosis congenita or selectively severe congenital neutropenia, Diamond-Blackfan anaemia, Diamond-Shwachman syndrome, and amegakaryocytic thrombocytopenia.  

Síndromes de la fallada medul·lar congènita a Vall d'Hebron
Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 05.01.2023, 12:53
Share it

Hereditary Angioedema Unit

In addition to providing multidisciplinary care for patients of all ages who suffer this condition, the objectives of Vall d’Hebron Hospital’s Hereditary Angioedema Unit include teaching and research in this field.

Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 09.02.2022, 12:04
Share it

Oral and Maxillofacial Surgery

The Oral and Maxillofacial Surgery specialty is defined as "the medical and surgical specialty dealing with the prevention, study, diagnosis, treatment and rehabilitation of the oral cavity and face, as well as the cervical structures that are directly or indirectly related to them".

Authorship: Vall d'Hebron
Creation date: 17.12.2021, 10:03
Modification date: 10.12.2024, 10:36
Share it

Oral and Maxillofacial Surgery

The Teaching Unit is led by the Oral and Maxillofacial Surgery Department, with participation from other specialisations such as General Surgery, Vascular Surgery, and the Traumatology Intensive Care Unit. 

Accredited places

1

Research groups
Document

Oral and maxillofacial surgery training itinerary

Why specialise at Vall d’Hebron?

  • Because we are a tertiary hospital with outstanding departments. The number of patients who pass through the centre offers great potential for learning and gaining of experience.
  • Because we cover most specialisations and you will have the opportunity to see complex conditions and to use cutting-edge diagnostic techniques and treatments.
  • Because our training programme can adapt to the initiative and vocation of each resident, with more emphasis on patient-contact or research according to their needs.

Clinical Nanomedicine and Advanced Therapies Research Centre. New Technologies and Craniofacial Microsurgery

Coro Bescós Atín

Coro Bescós Atín

Maxillofacial and Oral Surgery, General Hospital

Subscribe to our newsletters and be a part of Campus Life

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.